 Home > Medical News > Latest Medical News > Geli's new hepatitis B drug ASC22 Phase 2a Trial Announces Latest Results

Geli's new hepatitis B drug ASC22 Phase 2a Trial Announces Latest Results

 Last Update: 2021-05-22
 Source: Internet
 Author: User

Tags

flammable safety cabinet

surface solutions group

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On May 5, Gerry announced that the subcutaneously injectable PD-L1 antibody ASC22 has achieved good results in a phase 2a clinical trial against hepatitis B.

According to the press release, ASC22 (KN035, Envolimab) is a PD-L1 monoclonal antibody that can be used for subcutaneous injection.

The Phase 2a clinical trial of ASC22 is a single-dose escalation study, using three subcutaneous doses (0.

The data showed that after a single administration of ASC22 (0.

ASC22 showed good safety and tolerability in different dose groups, and all drug-related adverse reactions were grade 1.

Source: Guanlan Pharmaceutical

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.